Danielle Brill

Jul 13, 2026

Danielle Brill rated VRTX as Buy on Jul 13, 2026, setting a price target of 560. Shares have remained stable near 480.25, leaving the 560 target still in play.

Jul 13, 2026

On Jul 13, 2026, NBIX was given a Buy rating by Danielle Brill, with a target price of 200. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

Jul 13, 2026

BIIB received a Buy rating from Danielle Brill on Jul 13, 2026, aiming for 235. Price action was muted, as shares hovered around 209.03 despite the bullish outlook.

Jul 13, 2026

On Jul 13, 2026, Danielle Brill published a Buy outlook on ALNY, with a target of 410. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 288.06.

Jun 02, 2026

Danielle Brill on Jun 02, 2026 assigned PRAX a Buy rating, with a price target of 616. The recommendation remains pending validation as shares consolidate around 314.56.

May 19, 2026

On May 19, 2026, Danielle Brill initiated coverage on RAPP with a Buy rating and target of 56. The stock’s climb of 18.10% since the call highlights the foresight in the rating.

May 14, 2026

Danielle Brill issued a Buy recommendation for INSM on May 14, 2026, price target set at 185. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Apr 29, 2026

Danielle Brill rated BBIO as Buy on Apr 29, 2026, setting a price target of 102. The call has proven timely, with shares rising 17.11% toward the price target of 102.

Apr 29, 2026

On Apr 29, 2026, WVE was given a Buy rating by Danielle Brill, with a target price of 15. Despite the Buy call, shares fell from 5.95 to 5.95, challenging the optimistic stance.

Apr 14, 2026

MAZE received a Buy rating from Danielle Brill on Apr 14, 2026, aiming for 64. Momentum has favored the Buy call, with shares climbing from 29.18 to 29.18, rewarding those who trusted the recommendation.

Mar 18, 2026

On Mar 18, 2026, Danielle Brill published a Buy outlook on CLYM, with a target of 17. Shares gained 85.53%, underscoring the accuracy of the bullish outlook toward 17.

Mar 09, 2026

Danielle Brill on Mar 09, 2026 assigned DNTH a Buy rating, with a price target of 110. The Buy call aligned well with market performance, producing a gain of 24.50%.

Feb 27, 2026

On Feb 27, 2026, Danielle Brill reaffirmed IRON with a Buy rating, targeting 114. The recommendation was supported by strong follow-through as the stock rose from 75.98 to 75.98.

Jan 29, 2026

CNTA was rated Buy by Danielle Brill on Jan 29, 2026, with a price objective of 38. A bullish response from the market helped close the gap of -2.50 to the target.

Jan 08, 2026

On Jan 08, 2026, Danielle Brill initiated coverage on TECX with a Buy rating and target of 64. The stock’s climb of 60.02% since the call highlights the foresight in the rating.

Dec 16, 2025

Danielle Brill issued a Buy recommendation for PVLA on Dec 16, 2025, price target set at 190. Investors following the Buy call captured upside momentum, with shares now at 146.03.

Oct 14, 2025

On Oct 14, 2025, UPB was evaluated by Danielle Brill, who gave a Buy rating and target of 47. Investors saw limited payoff as shares fell short of the 47 target.

Jul 21, 2025

Danielle Brill rated JCAP as Buy on Jul 21, 2025, setting a price target of 24. The call has proven timely, with shares rising 13.40% toward the price target of 24.

Dec 10, 2024

On Dec 10, 2024, QURE was given a Strong Buy rating by Danielle Brill, with a target price of 52. The stock rallied 168.63% after the rating, narrowing the gap to the target of 52 and validating the bullish stance.

Oct 10, 2024

ARGX received a Strong Buy rating from Danielle Brill on Oct 10, 2024, aiming for 605. Momentum has favored the Buy call, with shares climbing from 876.25 to 876.25, rewarding those who trusted the recommendation.

Oct 10, 2024

On Oct 10, 2024, Danielle Brill published a Outperform outlook on RGNX, with a target of 18. Shares gained 37.24%, underscoring the accuracy of the bullish outlook toward 18.

Oct 10, 2024

Danielle Brill on Oct 10, 2024 assigned BMRN a Outperform rating, with a price target of 79. The call has struggled to gain traction, with shares losing 15.25%.

Oct 10, 2024

On Oct 10, 2024, Danielle Brill reaffirmed SRPT with a Outperform rating, targeting 150. Shares slid 84.63% despite the recommendation, highlighting downside risks.

Oct 10, 2024

On Oct 10, 2024, AGIO was evaluated by Danielle Brill, who gave a Outperform rating and target of 51. So far, the Buy call awaits clearer momentum, with shares flat at 40.55.

Oct 10, 2024

Danielle Brill rated XENE as Outperform on Oct 10, 2024, setting a price target of 50. The call has proven timely, with shares rising 67.58% toward the price target of 50.